Dr.Pieternella Lugtenburg's second opinion

Dr. Pieternella Lugtenburg

Hematology, Oncology

Netherlands

41 years of experience

Choose for Consultation

Area of expertise

Specialty

Hematology, Oncology

Subspecialty

Hematologic Oncology

Diseases

Waldenstrom Macroglobulinemia, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma, High-Grade B-Cell Lymphoma, Double Hit Lymphoma, Triple Hit Lymphoma, Primary Mediastinal Large B-cell Lymphoma, Primary Central Nervous System Lymphoma, Burkitt Lymphoma, Transformed Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Splenic Marginal Zone Lymphoma, MALT Lymphoma, Lymphoplasmacytic Lymphoma, Grey-zone Lymphoma, Peripheral T-cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Post-transplant Lymphoproliferative Disease, Anaplastic Large Cell Lymphoma, Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type, Extranodal NK/T-cell Lymphoma, Nasal Type, Hematologic Cancers

Procedures Performed

CT

Bone Marrow Aspiration

Bone Marrow Biopsy

18F Fluorodeoxyglucose - Positron Emission Tomography

Experience

Staff Hematologist, a Erasmus MC Cancer Institute

Rotterdam, Netherlands. From 1992

Substitute-Head, Hematology training, a Erasmus MC Cancer Institute

Rotterdam, Netherlands. 2011 - 2014

Chief of Medicine, a Department of Hematology, Erasmus MC Cancer Institute, Daniel den Hoed Cancer Center

Rotterdam, Netherlands. 1990 - 1992

Fellow, Hematology, a Erasmus MC Cancer Institute, Daniel den Hoed Cancer Center

Rotterdam, Netherlands. 1988 - 1990

Fellow, Internal Medicine, a Zuiderziekenhuis Rotterdam

Rotterdam, Netherlands. 1983 - 1988

Education

MD: Erasmus University Rotterdam

1983

Biography

Dr. Pieternella Lugtenburg has been a staff hematologist at Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands, since 1992. She has been associated with the Erasmus University Rotterdam since 1979, when she started as a student-teacher in the Department of Anatomy. Dr. Lugtenburg has a medical degree, cum laude, from Erasmus University Rotterdam, and board certifications in Internal Medicine and Hematology. PJ Lugtenburg has a Ph.D. from Erasmus University Rotterd...am, and the thesis title is "Somatostatin receptor scintigraphy in malignant lymphoma." Dr. Lugtenburg's research interests include clinical trials for novel therapies in non-Hodgkin’s lymphoma and Hodgkin’s lymphoma, the biological background of diffuse large B-cell lymphoma, and imaging in non-Hodgkin’s lymphoma and Hodgkin’s lymphoma. She has been a member of various professional societies, such as the Netherlands Society of Hematology (NVvH), the Dutch Society of Internal Medicine (NIV), the American Society of Hematology (ASH), and the European Hematology Association (EHA). Dr. Lugtenburg has also served in various board memberships of professional societies, such as Treasurer of EORTC Lymphoma Group, EORTC Lymphoma Group Executive Board, Chairman HOVON Lymphoma working group, etc. Moreover, Dr. Lugtenburg has been a member of national and international scientific working parties, such as the EORTC Lymphoma Group, PET coordinator EORTC Lymphoma Group, HOVON Imaging Group, HOVON Lymphoma Group, etc. She has served on various local and national working groups, such as the Coordinator Medicator electronic drug prescription Erasmus MC, Drugs Committee Erasmus MC, National DBC/DOT committee Hematology, etc. Besides, Dr. Lugtenburg has served on editorial boards, such as the Editorial Board of the Dutch Journal of Hematology (NtvH), the Editorial Board of Oncology and Hematology News International, and is a Regular reviewer for Blood, Dutch Journal of Hematology (NTvH), Leukemia and Lymphoma, European Journal of Cancer, Annals of Oncology, etc.

Affiliations

Member, Netherlands Society of Hematology (NVvH)

Member, Dutch Society of Internal Medicine (NIV)

Member, American Society of Hematology (ASH)

Member, European Hematology Association (EHA)

Executive Board Member, European Organisation for Research and Treatment of Cancer Lymphoma Group (2012-present)

Member, Advisory Board, Dutch Patient Advocacy Group, Hematon (2018-2020)

Advisory Committee Member, the Hemato-Oncology Foundation for Adults in the Netherlands, Pathology Facility (2016-2023)

Chairman, Advisory Board, Dutch Lymphoma Patient Advocacy Group (2013-2017)

Chairman, the Hemato-Oncology Foundation for Adults in the Netherlands, Lymphoma Working Group (2013-2020)

Treasurer, European Organisation for Research and Treatment of Cancer, Lymphoma Group (2012-2020)

Co-Chairman, the Hemato-Oncology Foundation for Adults in the Netherlands, Lymphoma Working Group (2008-2013)

Core Group Member, Regional Netherlands Comprehensive Cancer Organisation, Hemato-Oncology (2007-2015)

Scientific Secretary, the Hemato-Oncology Foundation for Adults in the Netherlands, Imaging Group (2006-2007)

You’re only one click away from a life-changing journey

Virtual health assistant powered by AI
350+ world-renowned Doctors

© 2024 Docus, Inc.

2810 N Church Street, Wilmington, DE 19802 United States